drugset / Trial / NCT01268163

The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer

NCT01268163 ↗

Phase 1 Completed 32 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the pharmacokinetic and safety characteristics of European Taxotere® and American Taxotere® with Hospira Docetaxel injection in patients with cancer.

Timeline

Start
2007-08
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Docetaxel Small molecule — Intravenous

Indications